LYRA News and Press, Lyra Therapeutics Inc. From 05/10/22

Lyra Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update PR Newswire In April 2022 , secured $100.5 million in gross proceeds in an at-the-market, private placement of common stock that is expected to support two pivotal data...

Lyra Therapeutics to Present at Upcoming Investor Conferences PR Newswire WATERTOWN, Mass. , May 5, 2022 /PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to ena...

Lyra Therapeutics Presents Positive Data from LANTERN Phase 2 Study of LYR-210 for Treatment of Chronic Rhinosinusitis at COSM 2022 PR Newswire LYR-210 provided up to 24 weeks of clinically meaningful global symptom improvement in CRS patients LYR-210 achieved ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Insider trading is a valuable metric for investors and can hint at future performance of these seven stocks. Alphabet ( GOOG )( GOOGL ): Co-founders’ sales accelerate, and executives joined them, but the...

Lyra Therapeutics Announces First Patient Treated in Phase 2 BEACON Clinical Trial of LYR-220 in Post-Surgical Chronic Rhinosinusitis Patients PR Newswire WATERTOWN, Mass. , April 25, 2022 /PRNewswire/ -- Lyra Therapeutics, Inc. (NASDAQ: LYRA), a clinical...

Today, we put Lyra Therapeutics in the spotlight for the first time. This small biopharma concern has disappointed investors since coming public in mid-2020. The drop in the shares has triggered some huge insider buying by insiders and beneficial owners of the stock via a capital ...

Lyra Therapeutics Announces Two Presentations at Upcoming COSM 2022 PR Newswire LYR-210 Data on Impact of Long-Acting Implantable Corticosteroid Matrices in Patients with CRS Selected as a Top Clinical Abstract Both Presentations Demonstrate Potential Benefit o...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Another day of trading is waiting for investors and we’re kicking it off with a look at the biggest pre-market stock movers for Wednesday! Source: Eric Urquhart/Shutterstock.com We’ve got buyout rumors...

Gainers: Checkmate Pharmaceuticals (CMPI) +332%. Sono Group (SEV) +66%. ToughBuilt Industries (TBLT) +55%. Petros Pharmaceuticals (PTPI) +40%. Axsome Therapeutics (AXSM) +25%. Cyren (CYRN) +22%. Super Micro Computer (SMCI) +21%. Pulse Biosciences (PLSE) +18%. Annexon (ANNX) +18%. Olema Pharma...

Gainers: Checkmate Pharmaceuticals CMPI +333%. Petros Pharmaceuticals (PTPI) +55%. Axsome Therapeutics AXSM +23%. Avinger (AVGR) +11%. Processa Pharmaceuticals (PCSA) +10%. Losers: Lyra Therapeutics (LYRA) -16%. Diffusion Pharmaceuticals (DFFN) -15...